CMX-2043 Treatment Limits Neural Injury Pathophysiology and Promotes Neurological and Cognitive Recovery in a Pediatric Porcine Traumatic Brain Injury Model
Journal of Neurotrauma · 2026
DOI: 10.1177/08977151251363584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurotrauma, 2026. Verfasst von Sarah L Schantz und 13 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Bioscience Center, University of Georgia, Athens, Georgia, USA. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Recovery of Function, Neuroprotective Agents, Cognition. Die Arbeit nennt 58 Literaturangaben.
Abstract (Originalsprache)
Traumatic brain injury (TBI) represents a major global health issue contributing to significant disability and mortality. The TBI-induced secondary injury cascade, characterized by neuroinflammation, neural cell death, and tissue damage, results in lifelong functional deficits. Alpha- N -[(R)-1, 2-dithiolane-3-pentanoyl] l -glutamyl- l -alanine (CMX-2043) is a novel alpha lipoic acid (ALA)-based therapeutic that has neuroprotective, anti-apoptotic, and anti-inflammatory properties that mitigate cellular, tissue, and functional deficits following TBI. In this study, we evaluated the therapeutic efficacy of CMX-2043 on neural injury severity and functional recovery in a clinically relevant porcine TBI model. CMX-2043 was administered 1-h post-TBI subcutaneously (SQ; n = 8) or intravenously (IV; n = 8) for a total of 5 days. Control piglets (placebo; n = 11) received saline subcutaneously. Magnetic resonance imaging (MRI), immunohistochemistry analysis, modified Rankin Scale (mRS) neurological evaluation, and social recognition testing (SRT) were evaluated up to 42 days post-TBI. MRI revealed that SQ and IV CMX-2043 administration reduced hemispheric swelling and atrophy, lesion volume, midline shift, and intracerebral hemorrhage and preserved diffusivity, cerebral blood flow, and white matter integrity. CMX-2043-mediated neuroprotection and regeneration were indicated by increased neural cell density, decreased neuroinflammation, and enhanced neurogenesis following SQ and IV administration. These cellular and tissue-level changes corresponded with reduced neurological deficits and rapid cognitive recovery as indicated by improved mRS and SRT results, respectively. Collectively, these results observed in a translational large animal porcine model suggest that CMX-2043 holds significant clinical value to potentially mitigate TBI pathophysiology and promote functional recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Regenerative Bioscience Center, University of Georgia, Athens, Georgia, USA.
- Department of Animal and Dairy Science, University of Georgia, Athens, Georgia, USA.
- Biomedical and Health Sciences Institute Neuroscience Program, University of Georgia, Athens, Georgia, USA.
- Department of Nutritional Sciences University of Georgia, Athens, Georgia, USA.
- Department of Kinesiology, Mary Frances Early College of Education, University of Georgia, Athens, Georgia, USA.
- Department of Interdisciplinary Biomedical Sciences, School of Medicine, University of Georgia, Athens, Georgia, USA.
ORCID-Profile: Sarah L Schantz
Zitieren
APA
Schantz, S. L., LePage, T. H., Dubrof, S. T., Sneed, S. E., Cheek, S. R., Park, H. J., Barany, D. A., Kinder, H. A., Duberstein, K. J., DeWahl, D. A., Baguisi, A. B., Stern, J. O., Kaiser, E. E., & West, F. D. (2026). CMX-2043 Treatment Limits Neural Injury Pathophysiology and Promotes Neurological and Cognitive Recovery in a Pediatric Porcine Traumatic Brain Injury Model. Journal of Neurotrauma. https://doi.org/10.1177/08977151251363584
Vancouver
Schantz SL, LePage TH, Dubrof ST, Sneed SE, Cheek SR, Park HJ, et al. CMX-2043 Treatment Limits Neural Injury Pathophysiology and Promotes Neurological and Cognitive Recovery in a Pediatric Porcine Traumatic Brain Injury Model. Journal of Neurotrauma. 2026. doi:10.1177/08977151251363584
BibTeX
@article{Schantz2026,
author = {Schantz, Sarah L and LePage, Taylor H and Dubrof, Stephanie T and Sneed, Sydney E and Cheek, Savannah R and Park, Hea Jin and Barany, Deborah A and Kinder, Holly A and Duberstein, Kylee J and DeWahl, David A and Baguisi, Alexander B and Stern, Jerry O and Kaiser, Erin E and West, Franklin D},
title = {CMX-2043 Treatment Limits Neural Injury Pathophysiology and Promotes Neurological and Cognitive Recovery in a Pediatric Porcine Traumatic Brain Injury Model},
journal = {Journal of Neurotrauma},
year = {2026},
doi = {10.1177/08977151251363584}
}
EUVIMED